In the last trading session, 1.67 million shares of the SELLAS Life Sciences Group Inc (NASDAQ:SLS) were traded, and its beta was 2.45. Most recently the company’s share price was $1.29, and it changed around $0.0 or 0.00% from the last close, which brings the market valuation of the company to $90.79M. SLS currently trades at a discount to its 52-week high of $1.72, offering almost -33.33% off that amount. The share price’s 52-week low was $0.50, which indicates that the current value has risen by an impressive 61.24% since then. We note from SELLAS Life Sciences Group Inc’s average daily trading volume that its 10-day average is 0.87 million shares, with the 3-month average coming to 577.83K.
SELLAS Life Sciences Group Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended SLS as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. SELLAS Life Sciences Group Inc is expected to report earnings per share of -0.1 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information
The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.3900 on recent trading dayincreased the stock’s daily price by 7.19%. The company’s shares are currently up 21.70% year-to-date, but still down -4.44% over the last five days. On the other hand, SELLAS Life Sciences Group Inc (NASDAQ:SLS) is 8.40% up in the 30-day period. We can see from the shorts that 8.61 million shares have been sold at a short interest cover period of 14.07 day(s).
The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to increase their stock price by 81.57% from its current value. Analyst projections state that SLS is forecast to be at a low of $6 and a high of $8.
SELLAS Life Sciences Group Inc (SLS) estimates and forecasts
SELLAS Life Sciences Group Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -9.15 percent over the past six months and at a 58.96% annual growth rate that is well above the industry average of 17.80%.
Forecasts for the next quarter put sales growth at �.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 61.44%.
SLS Dividends
SELLAS Life Sciences Group Inc’s next quarterly earnings report is expected to be released in December.
SELLAS Life Sciences Group Inc (NASDAQ:SLS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.24% of SELLAS Life Sciences Group Inc shares, and 7.36% of them are in the hands of institutional investors. The stock currently has a share float of 7.38%. SELLAS Life Sciences Group Inc stock is held by 35.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 3.9862% of the shares, which is about 1.79 million shares worth $2.13 million.
SUSQUEHANNA INTERNATIONAL GROUP, LLP, with 3.6594% or 1.64 million shares worth $1.95 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
